We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$508M
AUM Growth
+$11.3M
Cap. Flow
+$5.18M
Cap. Flow %
1.02%
Top 10 Hldgs %
26.12%
Holding
122
New
10
Increased
33
Reduced
37
Closed
13

Top Buys

Rank Stock Value
1
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$6.03M
2
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$5.53M
3
SPRY icon
ARS Pharmaceuticals
SPRY
+$5.15M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$5.12M
5
IRTC icon
iRhythm Holdings
IRTC
+$4.03M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$9.2M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$6.77M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$6.26M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$4.85M
5
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
+$4.16M

Sector Composition

Rank Sector Weight
1 Healthcare 95.94%
2 Industrials 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGFY
51
DELISTED
Signify Health, Inc.
SGFY
$4.37M 0.86%
+150,000
New +$3.45M
KRTX
52
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$4.34M 0.86%
19,310
-4,710
-20% -$953K
RCKT icon
53
Rocket Pharmaceuticals
RCKT
$340M
$4.32M 0.85%
270,790
– –
ARQT icon
54
Arcutis Biotherapeutics
ARQT
$3.36B
$4.22M 0.83%
220,985
+40,969
+23% +$928K
MRTX
55
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.16M 0.82%
59,516
-9,097
-13% -$673K
FATE icon
56
Fate Therapeutics
FATE
$286M
$4.1M 0.81%
183,000
– –
IMGN
57
DELISTED
Immunogen Inc
IMGN
$4.06M 0.8%
848,744
-91,500
-10% -$482K
CYTK icon
58
Cytokinetics
CYTK
$10.5B
$4.04M 0.8%
83,450
-550
-0.7% -$26.5K
NTLA icon
59
Intellia Therapeutics
NTLA
$1.49B
$3.99M 0.79%
71,380
– –
IQV icon
60
IQVIA
IQV
$38.7B
$3.68M 0.72%
20,300
+4,300
+27% +$942K
AMGN icon
61
Amgen
AMGN
$208B
$3.66M 0.72%
16,220
-70
-0.4% -$17K
CNC icon
62
Centene
CNC
$30.7B
$3.55M 0.7%
45,600
-2,450
-5% -$219K
BIIB icon
63
Biogen
BIIB
$30B
$3.54M 0.7%
13,252
-250
-2% -$53.1K
ALT icon
64
Altimmune
ALT
$552M
$3.44M 0.68%
269,100
+119,100
+79% +$1.76M
RLYB icon
65
Rallybio
RLYB
$84.5M
$3.38M 0.67%
29,173
-13,992
-32% -$1.25M
SGEN
66
DELISTED
Seagen Inc. Common Stock
SGEN
$3.38M 0.67%
24,670
-7,860
-24% -$1.28M
ARWR icon
67
Arrowhead Research
ARWR
$11.9B
$3.27M 0.64%
98,800
-18,000
-15% -$726K
BEAM icon
68
Beam Therapeutics
BEAM
$2.63B
$3.13M 0.62%
+65,700
New +$3.75M
TMO icon
69
Thermo Fisher Scientific
TMO
$213B
$2.96M 0.58%
5,840
– –
MDT icon
70
Medtronic
MDT
$109B
$2.55M 0.5%
31,551
+6,000
+23% +$539K
OLMA icon
71
Olema Pharmaceuticals
OLMA
$1B
$2.44M 0.48%
+883,056
New +$3.75M
CERT icon
72
Certara
CERT
$1.26B
$2.3M 0.45%
173,129
– –
VRTX icon
73
Vertex Pharmaceuticals
VRTX
$121B
$2.29M 0.45%
7,918
-200
-2% -$57.5K
REGN icon
74
Regeneron Pharmaceuticals
REGN
$78.5B
$2.29M 0.45%
3,320
+110
+3% +$69.2K
GILD icon
75
Gilead Sciences
GILD
$162B
$2.25M 0.44%
36,400
– –
1 2
3
4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sectoral Asset Management held 122 positions worth $508M, up 2.3% from $496M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sectoral Asset Management's Q3 2022 filing shows 10 new, 33 increased, 37 reduced and 13 closed positions. Its largest new stake was CTI BioPharma Corp. (DE) Common Stock: 968,300 shares worth $5.64M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Industrials.

  • Sectoral Asset Management's largest Q3 2022 buy was CTI BioPharma Corp. (DE) Common Stock: 968,300 shares worth $5.64M.
  • Sectoral Asset Management added most to iRhythm Holdings in Q3 2022, an estimated $4.03M increase.
  • Sectoral Asset Management's biggest Q3 2022 reduction was Silk Road Medical, Inc. Common Stock, cutting an estimated $4.85M.
  • Sectoral Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $9.2M.
  • Sectoral Asset Management's ten largest holdings make up 26% of its $508M portfolio in Q3 2022.
  • Sectoral Asset Management opened 10 new positions and closed 13 in Q3 2022.
  • Sectoral Asset Management's portfolio value rose 2.3% quarter-over-quarter to $508M.

Based on Sectoral Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.